Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences
RICHMOND, Calif., Aug. 30, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that members of the Company's senior management team are scheduled to participate in the following healthcare investor conferences in September.
Baird 2017 Global Healthcare Conference, New York, NY, September 6-7, 2017
Curt Herberts, Sangamo's chief business officer, is scheduled to present at 3:45 pm ET on Wednesday, September 6th.
Wells Fargo 2017 Healthcare Conference, Boston, MA, September 6-7, 2017
Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer, is scheduled to present at 10:00 am ET on Thursday, September 7th.
The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the Company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentations-at-upcoming-investor-conferences-300511623.html
SOURCE Sangamo Therapeutics, Inc.
Released August 30, 2017